PharmaCyte Biotech Statistics
Total Valuation
PMCB has a market cap or net worth of $4.28 million. The enterprise value is -$26.23 million.
| Market Cap | 4.28M |
| Enterprise Value | -26.23M |
Important Dates
The next estimated earnings date is Thursday, December 17, 2026, after market close.
| Earnings Date | Dec 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PMCB has 10.74 million shares outstanding. The number of shares has increased by 32.59% in one year.
| Current Share Class | 10.74M |
| Shares Outstanding | 10.74M |
| Shares Change (YoY) | +32.59% |
| Shares Change (QoQ) | +0.72% |
| Owned by Insiders (%) | 5.74% |
| Owned by Institutions (%) | 7.60% |
| Float | 10.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.15 |
| P/TBV Ratio | 0.15 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 40.30, with zero debt.
| Current Ratio | 40.30 |
| Quick Ratio | 40.25 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -43.99% and return on invested capital (ROIC) is -9.30%.
| Return on Equity (ROE) | -43.99% |
| Return on Assets (ROA) | -8.35% |
| Return on Invested Capital (ROIC) | -9.30% |
| Return on Capital Employed (ROCE) | -15.20% |
| Weighted Average Cost of Capital (WACC) | 8.50% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$10.32M |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -54.66% in the last 52 weeks. The beta is 0.77, so PMCB's price volatility has been lower than the market average.
| Beta (5Y) | 0.77 |
| 52-Week Price Change | -54.66% |
| 50-Day Moving Average | 0.40 |
| 200-Day Moving Average | 0.62 |
| Relative Strength Index (RSI) | 56.38 |
| Average Volume (20 Days) | 167,546 |
Short Selling Information
The latest short interest is 50,675, so 0.47% of the outstanding shares have been sold short.
| Short Interest | 50,675 |
| Short Previous Month | 70,104 |
| Short % of Shares Out | 0.47% |
| Short % of Float | 0.50% |
| Short Ratio (days to cover) | 0.65 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -5.46M |
| Pretax Income | -16.15M |
| Net Income | -20.63M |
| EBITDA | n/a |
| EBIT | -5.46M |
| Earnings Per Share (EPS) | -$2.20 |
Balance Sheet
The company has $30.51 million in cash and no debt, with a net cash position of $30.51 million or $2.84 per share.
| Cash & Cash Equivalents | 30.51M |
| Total Debt | n/a |
| Net Cash | 30.51M |
| Net Cash Per Share | $2.84 |
| Equity (Book Value) | 29.82M |
| Book Value Per Share | 2.60 |
| Working Capital | 30.21M |
Cash Flow
| Operating Cash Flow | -3.94M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -3.94M |
| FCF Per Share | -$0.37 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PMCB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -32.59% |
| Shareholder Yield | -32.59% |
| Earnings Yield | -552.26% |
| FCF Yield | -91.98% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on July 12, 2021. It was a reverse split with a ratio of 1:1,499.93.
| Last Split Date | Jul 12, 2021 |
| Split Type | Reverse |
| Split Ratio | 1:1,499.93 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |